|Podcasts|January 18, 2021

Psychiatry’s Gender Trouble

Michael F. Myers, MD, discusses issues of gender and sexuality, both today and in recent psychiatric history.

PSYCHPEARLS PODCAST

LGBTQ issues are some of the most pressing and difficult topics facing psychiatrists today. In this podcast, Psychiatric Times^TM interviews Michael F. Myers about gender and sexuality. Topics of discussion include:

Current subjects in gender and sexuality, including gender dysmorphia
How psychiatry’s understanding of sexuality and gender has changed over time
His own experience as a doctor during the AIDS crisis

Find out more about Dr Myers and his experience treating patients during the AIDS crisis in his new memoir, Becoming a Doctors’ Doctor.

Dr Myers is professor of Clinical Psychiatry and immediate past Vice-Chair of Education and Director of Training in the Department of Psychiatry & Behavioral Sciences at SUNY-Downstate Medical Center in Brooklyn, NY.

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related to this article

September 22nd, 2026

Clozapine and Late-Onset Agranulocytosis: A Potential Non–Life-Threatening Etiology

A case report and review of 13 similar cases suggest that late-onset clozapine neutropenia may sometimes reflect neutrophil margination rather than marrow suppression, with corticosteroids, granulocyte colony-stimulating factor, or lithium as possible, carefully monitored paths to continuing treatment.

September 17th, 2026

Embodied Technologies for Mental Health: Leveraging Synthetic Emotions for Dissociation and Anhedonia

How tuning body signals with closed-loop sound and chill tech may ease dissociation and anhedonia, offering drug-free add-ons to therapy.

September 9th, 2026

Choosing Sexual Function-Sparing Medications

Learn why SSRIs impair sex and how bupropion, PDE5 inhibitors, buspirone, and newer agents can prevent or reverse antidepressant sexual side effects.

Psychiatry’s Gender Trouble

Related to this article

Trending on Psychiatric Times

FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder

The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin

Using Psychotherapy for the Prevention of Relapse in Schizophrenia

Positive Phase 2 Topline Results: Remlifanserin for the Treatment of Alzheimer Disease Psychosis

The Top 7 Atypical Psychedelics: A Brief Clinical Guide